Admission Date:  [**2100-11-3**]              Discharge Date:   [**2100-11-16**]  Date of Birth:  [**2035-2-21**]             Sex:   M  Service: MEDICINE  Allergies: Imitrex / Biaxin  Attending:[**Doctor First Name 2080**] Chief Complaint: hemoptysis  Major Surgical or Invasive Procedure: rigid bronchoscopy, IR embolization of bleeding pulmonary vessels  History of Present Illness: 65 y/oM with stage IV lung CA on home 2L [**Hospital **] transferred from OSH with hemoptysis x 1 week and resultant Hct drop from baseline 28 to 17.
Patient first started coughing up dark clots of blood on Friday; states last hemoptysis was 1 day prior to transfer to [**Hospital1 18**], and was about a tablespoon of blood.
Patient had not required mechanical ventilation and was saturating well on room air in [**Hospital Unit Name 153**].
Of note, dyspnea has been a longterm complaint and patient was recently admitted for removal of y-stent in [**Month (only) 359**](first placed 2 mo ago).
Past Medical History: - Lung Cancer: poorly differentiated adenocarcinoma occluding R  main stem bronchus, s/p rigid bronchoscopy, tumor excision and Y-stent [**2100-7-28**].
lives alone  Family History: Mother: pancreatic cancer Maternal uncle: lung cancer Siblings: sister diabetes  Physical Exam: GEN: thin, fragile, NAD, occassionally labored breathing HEENT: EOMI, PERRLA, no supraclavicular or cervical lymphadenopathy, RESP: rhonchorus breath sounds throughout CV: RRR, S1 and S2 wnl, systolic murmur ABD: nd, +b/s, soft, nt, no masses or hepatosplenomegaly EXT: no c/c/e SKIN: no rashes/no jaundice/no splinters EXT limited ROM of right hip, minimal pain on palpatition of right trochanter Neuro: II-XII intact; no sensory deficits   Pertinent Results: Admission:  [**2100-11-3**] 05:48PM   HGB-9.2* calcHCT-28 [**2100-11-3**] 09:03AM   HCT-23.8* [**2100-11-3**] 02:58AM   WBC-5.4# RBC-2.98* HGB-9.0* HCT-25.8* MCV-87 MCH-30.0 MCHC-34.7 RDW-17.2* [**2100-11-3**] 02:58AM   NEUTS-80.1* LYMPHS-10.8* MONOS-8.3 EOS-0.6 BASOS-0.3 [**2100-11-3**] 02:58AM   PLT COUNT-235# [**2100-11-3**] 02:58AM   RET AUT-3.0 [**2100-11-3**] 02:58AM   PT-14.8* PTT-26.0 INR(PT)-1.3* [**2100-11-3**] 02:58AM   GLUCOSE-86 UREA N-29* CREAT-0.6 SODIUM-140 POTASSIUM-4.8 CHLORIDE-98 TOTAL CO2-27 ANION GAP-20 [**2100-11-3**] 02:58AM   ALT(SGPT)-11 AST(SGOT)-29 LD(LDH)-425* ALK PHOS-114 TOT BILI-1.5 .
Oxacillin RESISTANT Staphylococci MUST be reported as also          RESISTANT to other penicillins, cephalosporins, carbacephems,          carbapenems, and beta-lactamase inhibitor combinations.
Rifampin should not be used alone for therapy.
This isolate is presumed to be resistant to clindamycin based on          the detection of inducible resistance .
Furthermore, patients additional presenting complaint of right hip weakness found to result from tumor infiltration of right intertrochanteric space.
Underwent tracheal and esophageal stenting in hopes of improving the dysphagia.
Unfortunately, the force of the surrounding tumor resulted in near occlusion of esophageal stent 24hours after placement.
At time of discharge antibiotics, TPN were stopped, PICC line pulled and comfort measure were applied.
Now s/p rigid bronch with IP.
s/p IR procedure no further episodes of active hemopytsis.
After reviewing imaging decision made to first stent tracheal stent to protect airway prior to esophageal stent placement.
Unfortunately CT scan on day following stent placement revealed subtotal occlusion of distal esphagus.
Spoke with both Ortho onc as well and Radiation Oncology.
However after much discussion decision made to treat pain with and forego additional treatment measures.
Patient developed worsening post-obstructive pneumonia after esophageal stent placement.
Treatment with antibiotics discontinued after code discussion finalized.
Medications on Admission: - Atorvastatin 20 mg daily - Tamsulosin 0.4 mg Capsule, Sust.
Release 24 hr QHS - Menthol-Cetylpyridinium 3 mg Lozenge prn - Guaifenesin 600 mg Tablet Sustained Release 2 tabs [**Hospital1 **] - Omeprazole 20 mg Capsule, Delayed Release(E.C.)
daily - Docusate Sodium 100 mg Capsule [**Hospital1 **] - Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution q 6hrs prn - Acetylcysteine 20 % (200 mg/mL) Solution q 6hrs - Amoxicillin-Pot Clavulanate 875-125 mg Tablet x 4weeks - Benzonatate 100 mg Capsule TID - Cyclobenzaprine 10 mg Tablet TID - Oxycodone 5 mg Tablet q 4-6 hrs prn - Acetaminophen 325 mg q 6hrs prn - Lidocaine-Diphenhyd-[**Doctor Last Name **]-Mag-[**Doctor Last Name **] 200-25-400-40 mg/30 mL 5mL QID  - Codeine Sulfate 30 mg Tablet QID prn  Discharge Medications: 1. fentanyl 25 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr Transdermal Q72H (every 72 hours).
Disp:*1 Patch 72 hr(s)* Refills:*2* 2. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for anxiety.
4. morphine 10 mg/5 mL Solution Sig: One (1)  PO Q2H (every 2 hours) as needed for pain.
Disp:*1 bottle* Refills:*2* 5. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation Q4H (every 4 hours) as needed for wheezing.
Disp:*2 inhalers* Refills:*0* 6. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as needed for shortness of breath.
To address the bleeding, the team of interventional pulmonologists were able to a perform a bronchoscopy, a procedure which allows visualization of your airways.
The decision was made to place an esophageal stent in hopes of making swallowing easier.
A tracheal stent was placed prior to the esophageal stent to ensure airway protection.
Your pain was controlled with morphine and physical therapy worked with you to optimize your strength and ability to transfer.
You will be discharged with medications to control pain, decrease nasuea and improve breathing: - MORPHINE 5-10mg PO every 2 hours as needed for the pain - ZOFRAN 4mg tablets.
Take one tablet every 8 hours as needed for pain - ALBUTEROL Inhaler 2 PUFFS as needed for shortness of breath - ALBUTEROL Nebulizer treatment.
1 every 6hrs as needed for shortness of breath - LORAZAPAM 0.5 mg SL Q4H as needed for anxiety - Guaifenesin [**4-19**] mL PO/NG every four hours for cough  Followup Instructions: Please follow-up with Dr. [**Last Name (STitle) 27009**] and Dr. [**Last Name (STitle) 87543**] as needed and contact your hospice program with any questions or difficulties    Completed by:[**2100-11-16**
